There are two primary enzymes involved in prostaglandin synthesis: cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2)
Research investigations examine its interactions with the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor systems to explore peptide-driven metabolic behavior
You might feel like it isnt working as well if you expect immediate relief
Designed for adults seeking clinically guided weight loss support without insurance hassles or in-office visits
This is where MeAgain's GLP-1 app fits in, by centralizing dose and symptom logs, shot reminders, and clinician data sharing to make titration tracking and safety monitoring more auditable and timely
Quick Facts TypeDual GIP/GLP-1 Receptor Agonist CategoryWeight Loss / Metabolic AdministrationSubcutaneous injection, once weekly FrequencyOnce weekly Typical Dose2.5 15 mg/week (titrated) Cycle LengthOngoing (chronic therapy) Available Sizes5 mg, 10 mg, 30 mg, 60 mg vials Stability56 days after reconstitution Overview What is Tirzepatide